ACARIX — Acarix AB Share News
0.000.00%
- SEK236.94m
- SEK208.05m
- SEK7.36m
Brief: Acarix Receives Declarations Of Intent To Exercise Warrants Of Series TO 2
Brief: Acarix Board Approves Directed Share Issue Of Up To SEK 1.8 Mln
Brief: Acarix Q4 Gross Profit SEK 1.028 Million
Brief: Acarix CADScor System Now Listed On U.S. Federal Supply Schedule
Brief: Acarix Carries Out Directed Share Issue
Brief: Acarix Appoints Aamir Mahmood As New CEO
Brief: Acarix Appoints Aamir Mahmood As New CEO
Brief: Acarix Carries Out Directed Issue To Guarantors Following Completed Rights Issue
Brief: Acarix Q3 Loss Before Tax Narrows To SEK 17.3 Mln
Brief: Acarix Q3 EPS SEK -0.04
Brief: Acarix Rights Issue Generates Proceeds Of About SEK 54.3 Mln
Brief: Acarix' Cadscor® System Expands To Osteopathic Clinic In US
Brief: Acarix Resolves On A Rights Issue Of About SEK 54 Mln
Brief: Acarix Gets Initial Order From Emerging East African Market
Brief: Acarix Q2 EPS at SEK -0.05
Brief: Acarix Warrants Exercised To About 88%, Resolves On Directed Share Issue
Brief: Acarix Q1 Revenue at SEK 1.954 Million
Brief: Acarix Carries Out Directed Share Issue Amounting To About SEK 9.5 mln
Brief: Acarix Announces Strategic Sales Partnership